EUVIMEDEUVIMED entdecken
Open Access

Coumarin–furo[2,3- d ]pyrimidone hybrid molecules targeting human liver cancer cells: synthesis, anticancer effect, EGFR inhibition and molecular docking studies

Tianshuai Wang iD, Yumeng Gao, Fengxu Wu, Lun Luo, Junkai Ma, Yanggen Hu

RSC Medicinal Chemistry · 2024 · 15 (5) · 1565-1577

DOI: 10.1039/d3md00668a ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2024. Verfasst von Tianshuai Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hubei University of Medicine Shiyan 442000 Hubei China wtshuaiynn@163.com. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Hubei Provincial Department of Education.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coupling a furopyrimidone scaffold with coumarin through a hydrazide linker can effectively improve their synergistic anticancer activity targeting HepG2.

Autor:innen und Institutionen

  • School of Pharmacy, Hubei University of Medicine Shiyan 442000 Hubei China wtshuaiynn@163.com.
  • Hubei Key Lab of Wudang Local Chinese Medicine Research, School of Pharmacy, Hubei University of Medicine Shiyan 442000 Hubei China.

ORCID-Profile: Tianshuai Wang

Förderung

  • Hubei Provincial Department of Education

Zitieren

APA

Wang, T., Gao, Y., Wu, F., Luo, L., Ma, J., & Hu, Y. (2024). Coumarin–furo[2,3- d ]pyrimidone hybrid molecules targeting human liver cancer cells: synthesis, anticancer effect, EGFR inhibition and molecular docking studies. RSC Medicinal Chemistry, 15(5), 1565-1577. https://doi.org/10.1039/d3md00668a

Vancouver

Wang T, Gao Y, Wu F, Luo L, Ma J, Hu Y. Coumarin–furo[2,3- d ]pyrimidone hybrid molecules targeting human liver cancer cells: synthesis, anticancer effect, EGFR inhibition and molecular docking studies. RSC Medicinal Chemistry. 2024;15(5):1565-1577. doi:10.1039/d3md00668a

BibTeX
@article{Wang2024,
  author = {Wang, Tianshuai and Gao, Yumeng and Wu, Fengxu and Luo, Lun and Ma, Junkai and Hu, Yanggen},
  title = {Coumarin–furo[2,3- d ]pyrimidone hybrid molecules targeting human liver cancer cells: synthesis, anticancer effect, EGFR inhibition and molecular docking studies},
  journal = {RSC Medicinal Chemistry},
  year = {2024},
  volume = {15},
  number = {5},
  pages = {1565--1577},
  doi = {10.1039/d3md00668a}
}
Kostenlos starten →